7 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... characteristic features Clinical ... Active TB: • ... Treatment: Active ... #ActiveTB #LatentTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... characteristic features Clinical ... Active TB: • ... Treatment: Active ... #ActiveTB #LatentTB
Tuberculosis Testing

LATENT TB
• LTBI is diagnosed when an asymptomatic patient has a positive TST or IGRA
Tuberculosis Testing ... LATENT TB • ... tuberculosis ... #Latent #Active ... #LatentTB #ActiveTB
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Regimen for Multi-Drug ... Resistant Tuberculosis ... MultiDrugResistant #Tuberculosis
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Tuberculosis Infection ... for active or latent ... RAL-based ART regimen ... #Tuberculosis # ... TB #IDSA #Prevention
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
noncompliance • Clinical ... initiation Clinical ... effusions, CNS tuberculoma ... organizing PNA • Mycobacterium ... • Persistently active
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
reactivation of latent ... should be based on clinical ... Antimicrobial treatment ... 80% sensitive Tuberculous ... - Hemorrhage, tuberculomas